141 related articles for article (PubMed ID: 9007144)
1. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
Blum I; Vered Y; Lifshitz A; Harel D; Blum M; Nordenberg Y; Harsat A; Sulkes J; Gabbay U; Graff E
Isr J Med Sci; 1996 Dec; 32(12):1158-62. PubMed ID: 9007144
[TBL] [Abstract][Full Text] [Related]
2. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
Limpaphayom K; Taechakraichana N; Kittinunvorakoon C
J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
[TBL] [Abstract][Full Text] [Related]
3. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
Lai A; Zhang J; Ding L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
[TBL] [Abstract][Full Text] [Related]
4. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
5. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
Ushiroyama T; Sakuma K; Ikeda A; Ueki M
J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
[TBL] [Abstract][Full Text] [Related]
6. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS
Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355
[TBL] [Abstract][Full Text] [Related]
7. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
9. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
Ausmanas MK; Tan DA; Jaisamrarn U; Tian XW; Holinka CF
Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
[TBL] [Abstract][Full Text] [Related]
10. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
Ushiroyama T; Sakai M; Higashiyama T; Ikeda A; Ueki M
Gynecol Endocrinol; 2001 Feb; 15(1):74-80. PubMed ID: 11293929
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
Yasui T; Uemura H; Yoneda N; Irahara M; Aono T; Sunahara S; Hata K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):655-61. PubMed ID: 7636337
[TBL] [Abstract][Full Text] [Related]
13. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
Håkan Wallén N; Li N; Eriksson-Berg M; Landgren BM; Schenck-Gustafsson K; Hjemdahl P
Thromb Haemost; 2006 Dec; 96(6):862-3. PubMed ID: 17139389
[No Abstract] [Full Text] [Related]
14. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
15. Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol.
Carretti N; Florio P; Reis FM; Comai S; Petraglia F; Costa CV
Climacteric; 2007 Oct; 10(5):393-9. PubMed ID: 17852142
[TBL] [Abstract][Full Text] [Related]
16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
17. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women.
Carr BR; Khan N; Adams-Huet B; Kakarla N; Havelock JC; Gell J
Fertil Steril; 2006 Mar; 85(3):667-73. PubMed ID: 16500336
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen-progestin replacement therapy on plasma beta-endorphin levels in menopausal women.
Ortega E; Cuadros JL; Gonzalez AR; Ruiz E
Biochem Mol Biol Int; 1993 Apr; 29(5):831-6. PubMed ID: 8508135
[TBL] [Abstract][Full Text] [Related]
20. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
Kawai H; Furuhashi M; Suganuma N
Arch Gynecol Obstet; 2004 Mar; 269(3):192-5. PubMed ID: 13680264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
